The Role of Cellular-Spatial Neighborhoods in Tonsil Organoid Immunology.
细胞空间邻域在扁桃体类器官免疫学中的作用。
基本信息
- 批准号:10158393
- 负责人:
- 金额:$ 29.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-30 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAdjuvantAlgorithmsAntibodiesAntibody AffinityAntigen PresentationAntigenic VariationAntigensApoptosisArchitectureBiologyBone MarrowC-terminalCD8-Positive T-LymphocytesCell CycleCell physiologyCellsChelating AgentsColorCysteineCytomegalovirusCytometryCytotoxic T-LymphocytesDNADNA DamageDataData SetDiseaseEpitopesExcisionExposure toFlow CytometryFluorescenceFormalinFreezingGeneticGoalsGroupingHumanHuman Herpesvirus 4Humoral ImmunitiesImageImaging technologyImmuneImmune responseImmunologyIn SituIn VitroIndividualInfectionInfluenzaInfluenza vaccinationInternationalIsotopesLabelLanthanoid Series ElementsLeadLymphocyteMalignant NeoplasmsMapsMeasurementMeasuresMessenger RNAMetabolismMetalsMethodsMinorNatural Killer CellsNeighborhoodsOligonucleotidesOrganoidsParaffin EmbeddingPeriodicityPharmacologic SubstancePhenotypePhysiologyPolymersPopulationProductionProteinsProteomicsPublic HealthResolutionRoleSeriesSignal TransductionSignaling MoleculeStreptavidinSurfaceSystemT-LymphocyteTechnologyTestingTimeTissuesTonsilVaccinationVariantVirionVirusbasecell typecostdrug developmentfluorescence microscopegenetic manipulationhigh dimensionalityhuman diseaseimmune functionindexinginfluenza virus vaccineinsightinterestlymphoid structuresnew technologypandemic diseaseresponseseasonal influenzatechnology developmenttooltranscription factortumor immunologyuniversal influenza vaccineuniversal vaccinevaccine developmentvaccine response
项目摘要
PROJECT SUMMARY
New technologies such as mass cytometry have greatly expanded our ability to deepen our
understanding of the complexity of lymphocytes and related populations. The Stanford CCHI group has
been particularly attuned to the potential in following the lead of the Nolan lab in exploiting this
technology, with ground-breaking studies of T cells, NK cells, and cancer immunology. But a clear need
has been for high dimensional methods to interrogate tissue sections in a wide variety of circumstances.
This inspired several complementary efforts by Dr. Nolan and his group, specifically MIBI, which uses
metal labeled antibodies in a high-resolution format, and CODEX (CODetection by inDEXing), a multi-
parameter fluorescence-based imaging technology adaptable to most standard three-color fluorescence
microscopes, and currently capable of sensitively and quantitatively measuring more than 60 markers in a
single tissue. CODEX extends the deep phenotyping capabilities of multi-parameter flow cytometry while
enabling the associated spatial context of a multitude of cell types, including rare cell types implicated in
disease mechanisms. To achieve this high-parameter capability, antibodies against target epitopes are each
tagged with unique DNA oligonucleotides and iterative cycles of imaging and removal of corresponding tags is
performed to collect single cell proteomic measurements across all parameters. We will deploy CODEX for
deep phenotyping of the 2D and 3D architecture of tonsil organoids. Recognizing a growing international
biomedical and pharmaceutical interest in imaging applications to immunology, vaccine and drug
development, this Technology Development Project will extend the current features of CODEX to deep
phenotypic profiling of tonsil tissue architecture before and after exposure to influenza vaccine.
Specifically, the Davis lab has developed a unique tonsil organoid system that can be exposed to a flu
vaccine with subsequent production of high affinity antibodies several days to a week later. The versatility of
this organoid system provides an unprecedented opportunity to modify and test influenza vaccine constructs
and adjuvants in a fully human system and determine how best to trigger production of broadly neutralizing
influenza antibodies, a goal toward generating a universal vaccine. We will extract feature data with this
unprecedentedly deep data for the understanding of wholesale and minor tissue alterations that occur in
response to influenza vaccine challenge—enabling a first ever map of “tissue-omics” at the single cell
level for the influenza vaccine response. We will also take advantage of the various manipulations that
will be employed in Project 1 on this organoid system in order to gauge their effects on the organization of
these cells and use this to formulate hypotheses regarding the significance of particular cellular groupings
that we see in tonsils, which we refer to as “neighborhoods”.
项目摘要
新技术,如质谱细胞仪,大大扩展了我们的能力,加深我们的认识,
了解淋巴细胞和相关群体的复杂性。斯坦福大学CCHI小组
我特别注意到了跟随诺兰实验室的领导来利用这一点的潜力
技术,突破性的研究T细胞,NK细胞和癌症免疫学。但显然需要
一直是用于在各种情况下询问组织切片的高维方法。
这启发了诺兰博士和他的团队,特别是MIBI,
高分辨率格式的金属标记抗体,以及CODEX(CODetection by inDEXing),一种多功能
适用于大多数标准三色荧光的参数荧光成像技术
显微镜,目前能够灵敏和定量地测量60多个标记,
单个组织。CODEX扩展了多参数流式细胞术的深度表型分析能力,
使众多细胞类型的相关空间环境成为可能,包括涉及
疾病机制。为了实现这种高参数能力,针对靶表位的抗体各自是
用独特的DNA寡核苷酸标记,并重复成像和去除相应标记的循环,
以收集所有参数的单细胞蛋白质组学测量。我们将部署CODEX,
扁桃体类器官的2D和3D结构的深度表型分析。认识到日益增长的国际
对免疫学、疫苗和药物的成像应用感兴趣
开发,该技术开发项目将扩展CODEX的当前功能,以深入
暴露于流感疫苗之前和之后扁桃体组织结构的表型分析。
具体来说,戴维斯实验室已经开发出一种独特的扁桃体类器官系统,可以接触到流感
随后在几天至一周后产生高亲和力抗体。的多功能性
这种类器官系统为修饰和测试流感疫苗构建体提供了前所未有的机会
和佐剂,并确定如何最好地触发广泛中和的生产。
流感抗体,一个目标是产生一种通用疫苗。我们将提取特征数据与此
前所未有的深入的数据,了解批发和轻微的组织变化,发生在
对流感疫苗挑战的反应--首次在单细胞上绘制“组织组学”图谱
流感疫苗反应水平。我们还将利用各种操纵,
将在项目1中使用这个类器官系统,以衡量它们对组织的影响。
这些细胞,并使用它来制定关于特定细胞分组的重要性的假设
我们称之为“邻里”
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GARRY P NOLAN其他文献
GARRY P NOLAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GARRY P NOLAN', 18)}}的其他基金
Harmonizing single cell and spatial transcriptomics across HuBMAP organs to generate reproducible and robust maps
协调 HuBMAP 器官的单细胞和空间转录组学,生成可重复且稳健的图谱
- 批准号:
10818848 - 财政年份:2022
- 资助金额:
$ 29.39万 - 项目类别:
Stanford Tissue Mapping Center - STELLAR
斯坦福大学组织绘图中心 - STELLAR
- 批准号:
10818846 - 财政年份:2022
- 资助金额:
$ 29.39万 - 项目类别:
Spatial-Genomic Integrative Multi-Species Analysis of Lymph Node Metastasis
淋巴结转移的空间基因组综合多物种分析
- 批准号:
10401199 - 财政年份:2021
- 资助金额:
$ 29.39万 - 项目类别:
Application for Supplemental Funding from HUBMAP
向 HUBMAP 申请补充资金
- 批准号:
10228511 - 财政年份:2020
- 资助金额:
$ 29.39万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别: